Protocol for the development of an intervention... | HRB Open Research dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); const cookieDomain = window.location.hostname; const tld = buildTLD(); function buildTLD() { const domainParts = cookieDomain.split('.'); while (domainParts.length > 2) { domainParts.shift(); } return domainParts.join('.'); } function deleteCookie(cookieName) { if (!cookieName) { return; } const cookiePath = (cookieName.startsWith('retraction_warning_') || cookieName.startsWith('version_warning_')) ? '/articles/' + cookieName : '/'; // Yes, these three slightly different ways to try and remove cookies are necessary document.cookie = cookieName + '=; path=' + cookiePath + '; domain=' + cookieDomain + '; expires=Thu, 01 Jan 1970 00:00:01 GMT;'; document.cookie = cookieName + '=; path=' + cookiePath + '; domain=.' + tld + '; expires=Thu, 01 Jan 1970 00:00:01 GMT;'; document.cookie = cookieName + '=; path=' + cookiePath + '; expires=Thu, 01 Jan 1970 00:00:01 GMT;'; } function deleteGroupCookies(group) { if (!group) { return; } const domainData = OneTrust.GetDomainData(), cookies = domainData.Groups.filter(cookieGroup => cookieGroup.OptanonGroupId === group)[0].Cookies; cookies.forEach(cookie => deleteCookie(cookie.Name)); } function OptanonWrapper() { const cookieConsentGroups = []; for (group of OneTrust.GetDomainData().Groups) { cookieConsentGroups.push(group.OptanonGroupId); } OneTrust.OnConsentChanged(function(e) { const cookieConsentActiveGroups = OnetrustActiveGroups.split(',').filter(activeGroup => activeGroup); cookieConsentGroups.forEach(group => { if (!cookieConsentActiveGroups.includes(group)) { deleteGroupCookies(group); }; }); }); } window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://hrbopenresearch.org/js/vendor/ckeditor/' window.reactTheme = 'HRB'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); Skip to content HRB Open Research file_upload Submit your research search clear search menu close clear Search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Data Guidelines Prepublication Checks Production Process Article Processing Charges Finding Article Reviewers About How it Works For Reviewers National Steering Group Policies Glossary FAQs Contact Blog My Account Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://hrbopenresearch.org/articles/7-73" }, "headline": "Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the...", "datePublished": "2024-11-20T08:36:09", "dateModified": "2025-03-07T15:24:51", "author": [ { "@type": "Person", "name": "Joseph O'Shea" }, { "@type": "Person", "name": "Carmel Hughes" }, { "@type": "Person", "name": "Gerard Molloy" }, { "@type": "Person", "name": "Cathal Cadogan" }, { "@type": "Person", "name": "Akke Vellinga" }, { "@type": "Person", "name": "Tom Fahey" }, { "@type": "Person", "name": "Gail Hayward" }, { "@type": "Person", "name": "Paul Ryan" }, { "@type": "Person", "name": "Aoife Fleming" }, { "@type": "Person", "name": "Eimear Morrissey" }, { "@type": "Person", "name": "Laura Cooke" }, { "@type": "Person", "name": "Cristin Ryan" } ], "publisher": { "@type": "Organization", "name": "HRB Open Research", "logo": { "@type": "ImageObject", "url": "https://hrbopenresearch.org/img/AMP/HRB_image.png", "height": 566, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://hrbopenresearch.org/img/AMP/HRB_image.png", "height": 1200, "width": 127 }, "description": " Background Antimicrobial resistance is a significant global health challenge, exacerbated by inappropriate antibiotic prescribing, particularly in primary care where up to 50% of antibiotic prescriptions prescribed by general practitioners (GPs) and dispensed by community pharmacists (CPs) are deemed inappropriate. Respiratory tract infections (RTIs) are among the most common conditions leading to GP consultations and subsequent antibiotic prescribing, much of which is inappropriate as most RTIs are viral in nature or self-limiting bacterial infections. Point-of-care tests (POCTs) have emerged as tools to improve the diagnosis and appropriate treatment of RTIs. Objective This study aims to develop and test an intervention to improve the use of POCTs in managing RTIs involving GPs and CPs in Irish primary care, following the UK’s Medical Research Council’s (MRC) framework for complex intervention development, involving five work-packages (WPs). Methods WP1 involves creating best practice guidance for using POCT in managing RTIs, informed by a scoping review and validated with an expert Delphi panel. This guidance will be used to define target behaviour(s) for GPs and CPs related to POCT use. WP2 explores GP and CP perceived barriers and facilitators to these behaviours using the Theoretical Domains Framework, mapping influential domains to Behaviour Change Techniques to develop draft interventions. WP3 gathers patients’ perspectives on using POCTs for RTIs. In WP4, a task group will review and finalise the intervention(s). They will consider patients’ perspectives from WP3 and assess feasibility of the intervention(s). WP5 involves a proof-of-concept study to test the feasibility of the newly developed intervention(s). Conclusion A theoretically informed intervention(s) for using POCT(s) in the management of RTIs in primary care in Ireland will be developed and tested in a proof-of-concept study, following MRC guidance. Further refinement and larger studies will be needed to determine its effectiveness before widespread implementation. " } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://hrbopenresearch.org/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://hrbopenresearch.org/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://hrbopenresearch.org/articles/7-73", "name": "Protocol for the development of an intervention to improve the use..." } } ] } Home Browse Protocol for the development of an intervention to improve the use... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article O'Shea J, Hughes C, Molloy G et al. Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.12688/hrbopenres.13962.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Study Protocol Revised Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] Joseph O'Shea https://orcid.org/0000-0001-9860-9807 1 , Carmel Hughes 2 , Gerard Molloy https://orcid.org/0000-0002-7718-9898 3 , [...] Cathal Cadogan https://orcid.org/0000-0002-8778-0112 1 , Akke Vellinga https://orcid.org/0000-0002-6583-4300 4 , Tom Fahey https://orcid.org/0000-0002-5896-5783 5 , Gail Hayward 6 , Paul Ryan 7 , Aoife Fleming 8 , Eimear Morrissey https://orcid.org/0000-0003-1452-6145 9,10 , Laura Cooke 11 , Cristin Ryan 1 Joseph O'Shea https://orcid.org/0000-0001-9860-9807 1 , Carmel Hughes 2 , [...] Gerard Molloy https://orcid.org/0000-0002-7718-9898 3 , Cathal Cadogan https://orcid.org/0000-0002-8778-0112 1 , Akke Vellinga https://orcid.org/0000-0002-6583-4300 4 , Tom Fahey https://orcid.org/0000-0002-5896-5783 5 , Gail Hayward 6 , Paul Ryan 7 , Aoife Fleming 8 , Eimear Morrissey https://orcid.org/0000-0003-1452-6145 9,10 , Laura Cooke 11 , Cristin Ryan 1 PUBLISHED 07 Mar 2025 Author details Author details 1 School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Leinster, Ireland 2 School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, UK 3 School of Psychology, College of Arts, Social Sciences and Celtic Studies, University of Galway, Galway, County Galway, Ireland 4 School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland 5 Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland 6 Department of Primary Care Health Sciences, University of Oxford, Oxford, England, UK 7 Irish College of General Practitioners, Dublin, Ireland 8 School of Pharmacy, University College Cork, Cork, Ireland 9 Centre for Health Research Methodology, School of Nursing and Midwifery, University of Galway, Galway, Ireland 10 Institute for Clinical Trials, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland 11 The Irish Platform for Patient Organisations, Science, and Industry (IPPOSI), Dublin, Ireland Joseph O'Shea Roles: Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Writing – Original Draft Preparation, Writing – Review & Editing Carmel Hughes Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Gerard Molloy Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Cathal Cadogan Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Akke Vellinga Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Tom Fahey Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Gail Hayward Roles: Conceptualization, Methodology, Writing – Review & Editing Paul Ryan Roles: Conceptualization, Methodology, Writing – Review & Editing Aoife Fleming Roles: Conceptualization, Methodology, Writing – Review & Editing Eimear Morrissey Roles: Conceptualization, Methodology, Writing – Review & Editing Laura Cooke Roles: Methodology, Writing – Review & Editing Cristin Ryan Roles: Conceptualization, Data Curation, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS Abstract Background Antimicrobial resistance is a significant global health challenge, exacerbated by inappropriate antibiotic prescribing, particularly in primary care where up to 50% of antibiotic prescriptions prescribed by general practitioners (GPs) and dispensed by community pharmacists (CPs) are deemed inappropriate. Respiratory tract infections (RTIs) are among the most common conditions leading to GP consultations and subsequent antibiotic prescribing, much of which is inappropriate as most RTIs are viral in nature or self-limiting bacterial infections. Point-of-care tests (POCTs) have emerged as tools to improve the diagnosis and appropriate treatment of RTIs. Objective This study aims to develop and test an intervention to improve the use of POCTs in managing RTIs involving GPs and CPs in Irish primary care, following the UK’s Medical Research Council’s (MRC) framework for complex intervention development, involving five work-packages (WPs). Methods WP1 involves creating best practice guidance for using POCT in managing RTIs, informed by a scoping review and validated with an expert Delphi panel. This guidance will be used to define target behaviour(s) for GPs and CPs related to POCT use. WP2 explores GP and CP perceived barriers and facilitators to these behaviours using the Theoretical Domains Framework, mapping influential domains to Behaviour Change Techniques to develop draft interventions. WP3 gathers patients’ perspectives on using POCTs for RTIs. In WP4, a task group will review and finalise the intervention(s). They will consider patients’ perspectives from WP3 and assess feasibility of the intervention(s). WP5 involves a proof-of-concept study to test the feasibility of the newly developed intervention(s). Conclusion A theoretically informed intervention(s) for using POCT(s) in the management of RTIs in primary care in Ireland will be developed and tested in a proof-of-concept study, following MRC guidance. Further refinement and larger studies will be needed to determine its effectiveness before widespread implementation. READ ALL READ LESS Keywords Point-of-care test, respiratory tract infection, primary care, community pharmacist, general practitioner, antibiotics, antimicrobial resistance Corresponding Author(s) Cristin Ryan ( [email protected] ) Close Corresponding author: Cristin Ryan Competing interests: No competing interests were disclosed. Grant information: Health Research Board [ILP-HSR-2022-006].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2025 O'Shea J et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: O'Shea J, Hughes C, Molloy G et al. Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.12688/hrbopenres.13962.2 ) First published: 20 Nov 2024, 7 :73 ( https://doi.org/10.12688/hrbopenres.13962.1 ) Latest published: 07 Mar 2025, 7 :73 ( https://doi.org/10.12688/hrbopenres.13962.2 ) Revised Amendments from Version 1 This updated version of the PREDICTORS study protocol incorporates revisions based on peer review feedback to enhance clarity and provide additional context. The background section now includes details on antibiotic prescribing rates in Ireland and expands on existing POCTs commonly used in Irish primary care. The economic considerations section has been refined to summarize key findings from Fawsitt et al., emphasizing the cost-effectiveness and budget impact of CRP POCT implementation. In the methods section, we have clarified that grey literature will be reviewed alongside peer-reviewed sources in the scoping review. Recruitment criteria have been expanded to consider additional demographic factors, such as age and urban versus rural practice settings, to ensure a diverse participant sample. Further clarification has been added regarding qualitative data analysis, specifying the roles of the primary researcher and analysis team in coding and validation. The discussion has been revised to address the role of payers in intervention implementation, noting potential reimbursement challenges. The description of the POCT implementation model now acknowledges that WP4 and WP5 will be shaped by earlier findings, allowing for a range of potential intervention models, including collaborative or independent GP-CP practice. The guideline specificity section has been updated to reflect that the Delphi study will determine where and by whom POCT should be used, with the final guidance incorporating only consensus-based statements while maintaining POCT-specific recommendations. These updates enhance the clarity and completeness of the protocol, ensuring alignment with the study's aims and the practical considerations of POCT implementation in Irish primary care. This updated version of the PREDICTORS study protocol incorporates revisions based on peer review feedback to enhance clarity and provide additional context. The background section now includes details on antibiotic prescribing rates in Ireland and expands on existing POCTs commonly used in Irish primary care. The economic considerations section has been refined to summarize key findings from Fawsitt et al., emphasizing the cost-effectiveness and budget impact of CRP POCT implementation. In the methods section, we have clarified that grey literature will be reviewed alongside peer-reviewed sources in the scoping review. Recruitment criteria have been expanded to consider additional demographic factors, such as age and urban versus rural practice settings, to ensure a diverse participant sample. Further clarification has been added regarding qualitative data analysis, specifying the roles of the primary researcher and analysis team in coding and validation. The discussion has been revised to address the role of payers in intervention implementation, noting potential reimbursement challenges. The description of the POCT implementation model now acknowledges that WP4 and WP5 will be shaped by earlier findings, allowing for a range of potential intervention models, including collaborative or independent GP-CP practice. The guideline specificity section has been updated to reflect that the Delphi study will determine where and by whom POCT should be used, with the final guidance incorporating only consensus-based statements while maintaining POCT-specific recommendations. These updates enhance the clarity and completeness of the protocol, ensuring alignment with the study's aims and the practical considerations of POCT implementation in Irish primary care. See the authors' detailed response to the review by Guido Schmiemann See the authors' detailed response to the review by Sajal Saha READ REVIEWER RESPONSES Introduction Antimicrobial resistance is a widely recognised global health challenge 1 . It results in reduced efficacy of antibacterial, antiparasitic, antiviral and antifungal drugs, making the treatment of patients difficult, costly, or even impossible 2 . While antibiotic resistance develops naturally as bacteria adapt to antibiotic use, overuse and misuse accelerates this process 3 . In Ireland, antibiotic prescribing rates in primary care are slightly above the EU average, according to the European Centre for Disease Prevention and Control report 4 . This highlights the need for interventions to optimise prescribing practices and reduce unnecessary antibiotic use. Most antibiotic prescribing (80–90%) occurs in primary care, prescribed by general practitioners (GPs) and dispensed by community pharmacists (CPs). However, up to 50% of this prescribing is deemed inappropriate 3 – 6 . Accurately diagnosing and treating respiratory tract infections (RTIs) is particularly challenging 7 , with large variations reported between what is prescribed and what should be prescribed, especially considering the viral and self-limiting nature of most RTIs 8 , 9 . Key drivers of antibiotic prescribing include perceived patient pressure, fear of complications of untreated infections, the perception that prescribing antibiotics is the low-risk option because of their good tolerability profile, diagnostic uncertainty, and under-estimation of antibiotic resistance by healthcare providers 10 . Over the last four decades, no major new types of antibiotics have made it to market 2 . It is therefore essential to preserve the efficacy of existing drugs by minimising the development and spread of resistance to them, while efforts to develop new treatment options proceed 2 . Antimicrobial stewardship (AMS) programmes have been established to improve the appropriate use of antibiotics and conserve the diminishing antibiotic reserve. GPs and CPs are the most important antimicrobial stewards in primary care 11 . They are the first point of contact of patients with infections and CPs are well positioned to provide comprehensive patient care through liaison with GPs 12 . A systematic review and meta-analyses of 18 AMS trials found that implementation of AMS programmes by a GP-CP inter-professional team resulted in reductions in antibiotic prescribing (OR 0.93, 95%CI, 0.90-0.95) and improvements in guideline-adherent antibiotic prescribing (OR 1.72, 95%CI, 1.04-2.84) 13 . Whilst inter-professional collaboration in primary care has a positive impact on patient care, a recent overview of reviews by Rawlinson et al. recommended that key barriers and facilitators at organisational and inter-individual levels should be explored, and specific contexts considered, to enhance successful implementation of inter-professional collaboration in primary care 14 . Some AMS interventions that have demonstrated effectiveness in reducing antibiotic prescribing include the use of delayed prescriptions ( i.e. , prescribed an antibiotic but advised the patient not to start taking the course unless their condition deteriorated or failed to improve after a set period) 15 , education interventions, audit of prescribing practices and linked feedback, enhanced communication skills training for healthcare professionals, and the use of point-of-care tests (POCTs; i.e., testing of patients at the time and place of care) 16 – 20 . POCT use is not new to Irish primary care. Blood glucose monitoring, urinalysis, international normalised ratios, urinary beta-human chorionic gonadotropin testing, PCR testing for COVID-19, Flu A and Flu B, urinary toxicology screening, haemoglobin, coagulation, and HbA1c testing are examples of POCTs that have been successfully incorporated into general practices. Several POCTs can also be used to improve the diagnostic certainty of RTIs ( i.e., support differentiation between viral and bacterial infections in patients presenting with symptoms of RTIs) 3 . Rapid antigen detection tests (RADT) can be used to detect Group A Streptococcus , and report good sensitivity (86%; 95% CI 83–88) and specificity (96%; CI 94–97) 21 , 22 . Procalcitonin, a biomarker whose serum concentrations are elevated in response to systematic inflammation caused by bacterial infection, can be tested for in the diagnosis of sepsis 23 , 24 . A Cochrane review by Tonkin-Crine et al. found that procalcitonin-guided management significantly reduced antibiotic prescribing for acute RTIs in primary care 7 . The same review reported that C-reactive protein (CRP) POCTs also significantly reduced antibiotic prescribing in patients with RTIs in primary care 7 . CRP POCTs have been endorsed by a European expert panel to address antibiotic overuse for lower RTIs. They suggest developing guidelines, reimbursement structures, and educational and communication tools to promote local access and uptake of CRP POCTs 10 . While the integration of POCTs into national guidelines and clinical practice varies, countries where POCTs are widely used, including Denmark, Norway, Sweden and the Netherlands, have lower antibiotic use compared to those where POCTs are not widely implemented 9 . However, this association is not necessarily causal. Numerous interacting factors, including pre-existing antibiotic prescribing levels, national prescribing guidelines, AMS programmes, and culturally determined healthcare provider and patient-related factors, also play a significant role 3 . While this study does not focus on economic evaluation, prior research has highlighted the cost-effectiveness of CRP POCTs in Ireland. Fawsitt et al. evaluated the cost-effectiveness and budget impact of a national CRP POCT programme to guide antibiotic prescribing for acute RTIs in Irish primary care 25 . Their findings indicated that CRP POCT, particularly when combined with enhanced communication skills training for GPs, effectively reduces antibiotic prescribing but increases overall healthcare costs. The study suggested that although implementing CRP POCT would be costly, potential budget savings could be achieved depending on the implementation scenario 25 . Further research is needed to determine how POCTs should be implemented in Irish primary care for managing RTIs. Introducing new practices and services necessitates changes in both individual and collective behaviour, which requires understanding the factors that influence behaviour within the specific context 26 . Behaviour theories, which explicitly describe the structural and psychological processes that regulate behaviour and behaviour change, are important in understanding behaviours and guiding the development of interventions that target behaviours 26 . We propose to develop a theory-informed behaviour change POCT(s) intervention(s) for managing RTIs in primary care in Ireland, involving both GPs and CPs. Aim and objectives The aim of this research programme is to develop an intervention(s) involving GPs and CPs in primary care to improve the use of POCT(s) in the management of RTIs and to test its proof-of-concept, addressing the following objectives: To develop best practice guidance for using POCTs in the management of RTIs in primary care, informed by a scoping review and validated using a Delphi consensus technique To explore GPs’ and CPs’ perceived barriers and facilitators to using POCTs in the management of RTIs in the Irish primary care context and develop a draft intervention(s) To explore patients’ views on the use of POCTs to guide treatment decisions in the management of RTIs in the Irish primary care context To obtain the views of an expert task group on the draft intervention(s), further refine the draft intervention(s) and select the final intervention(s) for proof-of-concept testing To test the newly developed intervention(s) in a proof-of-concept study. Methods This study involves five main work-packages (WPs): (i) Development of guidance; (ii) qualitative interviews with GPs and CPs; (iii) qualitative interviews with patients; (iv) intervention development with a task group, and; (v) a proof-of-concept study ( Figure 1 ). A Patient and Public Involvement (PPI) panel consisting of three members will be involved throughout the research programme (in particular WP3 and WP4). Figure 1. Research overview for the PREDICTORS study. Abbreviations: CP community pharmacist, GP general practitioner, MRC Medical Research Council, RTI respiratory tract infection, WP work-package. WP1: The development of best practice guidance for using POCTs in the management of RTIs in primary care This WP involves two components, a scoping review and a Delphi consensus study. Scoping review A scoping review will be undertaken to identify published national and international evidence-based guidelines, systematic reviews, quality indicators, and individual studies that focus on the use of POCTs in the management of RTIs. The scoping review will summarise the evidence to inform the development of best practice guidance for using POCTs in the management of RTIs in primary care ( i.e., by GPs and CPs) 27 . Databases including PubMed, EMBASE, Web of Science, and CINAHL will be searched using terms such as ‘point-of-care test’, ‘antibiotics’, and ‘primary care’. In addition to peer-reviewed studies, grey literature, including national reports and prior healthcare projects in Ireland, will be reviewed. This will ensure that all relevant insights on POCT implementation in primary care are captured. The search strategy has already been developed in collaboration with the subject librarian in Trinity College Dublin. All titles and abstracts will be imported into the online platform Covidence ® to manage the review process. Two reviewers will independently screen search results for eligibility and extract data using a form developed and piloted by both reviewers. Any disagreements during screening and data extraction will be resolved through discussion with a third reviewer. Delphi consensus study The findings of the scoping review will be used to inform draft best practice guidance. This will be developed by members of the team following guidance from the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument 28 . A Delphi consensus technique, a long-established method which allows informed decision-making through obtaining consensus from expert opinion, will then be used to validate this initial draft and to agree on its content 29 – 31 . A Delphi panel, consisting of national clinical experts (n = 20) including respiratory physicians, microbiologists, GPs, and CPs with special interests in respiratory disease, POCTs, and AMS will be purposively recruited from the research team’s professional network. Each panel member will be provided with the best practice guidance statements in a web-based questionnaire format ( i.e., Qualtrics ® 32 ) and will be asked to agree on the content of the guidance by independently rating their level of agreement with each guidance statement using a 5-point Likert scale (1= strongly disagree, 5 = strongly agree). Members of the Delphi panel will have the opportunity to provide commentary on each guidance statement to make suggestions for change. Statements with an overall lower quartile of ≥4 will be retained for inclusion in the final guidance, whilst those with an overall upper quartile of ≤2 will be removed 33 . Statements with an interquartile range that includes 3 will be reviewed within the core research team, modified and recirculated for review by the expert panel in a second round Delphi questionnaire 33 . In this second round, panel members will receive their own individual and group responses. Following further review, only those guidance statements with an overall lower quartile of ≥4 will be included. It is anticipated that three Delphi rounds will be required to achieve consensus on the final content of the guidance. The Delphi study will assess expert opinions on the appropriate setting and provider for POCT use, specifically whether testing should be conducted in general practice, community pharmacy, or both, and whether it should be performed by GPs, CPs, or other healthcare professionals. The final guidance will reflect consensus statements that emerge from this process, defining the setting and provider for POCT use. However, the remainder of the guidance will be POCT-specific and will not vary based on these factors, ensuring consistency in best practice recommendations regardless of the implementation setting. WP2: Qualitative interviews with GPs and CPs to explore their views and perceived barriers and facilitators to using POCTs in the management of RTIs in primary care This WP will explore the views of GPs and CPs regarding the use of POCT(s) in the management of RTIs. The Consolidated Criteria for Reporting Qualitative Research (COREQ) will be used throughout and in the reporting of this WP 34 . Study design A qualitative study design, using individual semi-structured interviews, was chosen as this methodology will facilitate a detailed examination of the barriers and facilitators to the behaviour under investigation, i.e., using POCT(s) in the management of RTIs by GPs and CPs. The exact specificity of the behaviour pertaining to using POCTs in the management of RTIs will be defined based on the best practice guidance produced in WP1, following guidance from Atkins et al. 26 If multiple behaviours are identified from the guidance, we will prioritise behaviours following Atkins et al. ’s recommendations and select a maximum of two behaviours to target for each professional group (GPs and CPs). In selecting the behaviour to target, the following will be considered: (i) How modifiable the behaviour is likely to be; (ii) how central it is in bringing about the desired change in clinical practice; (iii) probable/potential positive or negative effects on other related behaviours if change occurs; and (iv) its amenability to measurement 26 . The behaviours will be explored using the Theoretical Domains Framework (TDF) V2.0 and then mapped to Behavioural Change Techniques (BCTs), which are the active ingredients of behaviour change interventions ( further details provided below ). This approach has been used in the development of other complex interventions targeting healthcare professionals’ behaviour 35 – 38 . Sampling and recruitment of GPs and CPs GPs working in general practice and pharmacists working in the community setting, who have prescribed/dispensed antibiotics for RTIs will be eligible for inclusion. The Health Research Board (HRB) Primary Care Clinical Trials Network (CTN) will facilitate the recruitment of GPs by initiating contact between prospective GP participants and the researcher. Once GPs are recruited, they will assist in recruiting CPs. It is anticipated that two GPs and two CPs will be recruited per Community Health Organisation (CHO) in which they work. CHOs in Ireland are regional structures established by the Health Service Executive to deliver health and social care services at a local level. There are nine CHOs across the country, each responsible for providing a range of primary care, social care, mental health, and community health services to their respective populations. With nine CHOs, we expect to recruit 18 GPs and 18 CPs in total. This approach to recruitment will ensure geographical diversity and that a mixture of GPs and CPs working in urban and rural areas are recruited. These factors may influence familiarity with and accessibility to POCTs. Furthermore, we will strive for gender balance in our recruitment. Data analysis will be conducted in tandem with data collection; therefore, recruitment will continue until data saturation is reached. Participants will be remunerated for their time (€100 per interview). Written, informed consent will be required, after which the researcher (O’Shea) will schedule the online interview ( e.g., Microsoft Teams) at a date and time best suited to the participant and the researcher. Topic guides for GP and CP interviews Separate topic guides will be developed for GPs and CPs reflecting the specificity of the target behaviours as noted above. The guides will be largely based on the TDF V2.0, and informed by existing literature on barriers and facilitators to POCT use in primary care 23 , 39 – 41 . The TDF V2.0 integrates insights from 33 behaviour change theories into 14 key domains (knowledge; skills; social/professional role and identity; beliefs about capabilities; beliefs about consequences; reinforcement; intentions; memory, attention and decision processes; environmental context and resources; social influences; emotion; optimism; goals; and behavioural regulation), each representing distinct aspects of behaviour and can be used to identify barriers and facilitators to components of behaviour 26 . It is possible that not all of the 14 domains will be considered relevant to the target behaviour by the research team and therefore some may be omitted from the topic guides. Open questions will be asked for each domain followed by prompts and cues to probe more deeply to explore barriers and facilitators to each domain. It is anticipated that each interview will last approximately 30–40 minutes. Pilot interviews with GPs and CPs will be undertaken to ensure clinical relevance. Members of the team experienced in behavioural change will also review the GP and CP topic guides. Participants will also be asked their views on potential POCT intervention components, and how GPs and CPs could work together to deliver these. Data management and analysis Interviews will be audio and video recorded, transcribed verbatim using a transcription service, anonymised, and entered into NVivo ® 42 . Codes will be assigned to differentiate between GP and CP participants, together with a two-digit identification number. All identifiers will be removed during transcription and only anonymised transcripts will be available to the research team for analysis using NVivo ® . Data analysis will be conducted in tandem with data collection; therefore, the topic guides will undergo iterative development and refinement. Analysis of qualitative interviews will be performed by the primary researcher (O’Shea). A 20% random sample of transcripts will be reviewed by a second researcher (the Principal Investigator (Ryan)) to enhance reliability. Analysis will follow the framework method 43 , with the TDF as the framework. Further content analysis of each domain will be undertaken to explore barriers and facilitators within each domain. The research team will oversee the final coding framework to ensure consistency, with final coding completed only after team consensus is reached. Development of draft interventions The TDF domains identified as feasible intervention targets will be mapped to BCTs using the BCT Ontology (BCTO) 44 . The BCTO provides a more comprehensive and structured framework for categorising and understanding BCTs (the active ingredients of behaviour change interventions), representing specific strategies designed to modify behaviour 44 . Cane et al. ’s mapping matrix will be used in this mapping process 45 , ensuring that each selected TDF domain is translated into actionable BCTs within the BCTO framework 45 , 46 . Operationalising BCTs into actionable intervention components for community pharmacy and general practice will be undertaken once WP3 is completed, so that patients’ perspectives can be considered. The research team will convene to review results, resolve discrepancies, and determine how to implement the identified BCTs to develop draft intervention(s) aimed at improving the use of POCT(s) in the management of RTIs in primary care. WP3: Qualitative interviews with patients to explore their views on receiving POCTs to guide treatment in the management of RTIs A qualitative study to explore patients’ views on receiving POCTs to guide treatment in the management of RTIs will be undertaken. The COREQ will also be used throughout and in the reporting of this WP 34 . Sampling and recruitment of patients Patients/carers (aged 18 years or older) will be eligible to take part if they have previously received an antibiotic for a RTI or if someone they care for (no age limits) has been given an antibiotic for a RTI. GPs and CPs participating in WP2 will be asked to provide study information to potential patient/carer participants, and instruct them to contact the researcher (O'Shea) if they are interested in taking part. It is intended that this approach to recruitment will ensure geographical diversity and that a mixture of patients/carers from urban and rural areas are recruited. We anticipate that 15 patients/carers will provide sufficient information power for WP3 47 . Participants will be remunerated for their time (€100 per interview). Written, informed consent will be required, after which the researcher (O’Shea) will schedule the online interview ( e.g., Microsoft Teams) at a date and time best suited to the participant and the researcher. Topic guide for patient interviews The topic guide and study documentation ( e.g., participant information leaflet) will be co-developed by the researcher (O’Shea), Principal Investigator (Ryan), and PPI panel with input from members of the wider team. This guide will be informed by existing literature on barriers and facilitators to POCT in primary care 48 – 50 . It is anticipated that each interview will last approximately 30–40 minutes. Data analysis will be conducted in tandem with data collection; therefore, the topic guides will undergo iterative development and refinement. Open questions will be asked followed by prompts and cues to probe more deeply to explore participants’ views on and experience with POCTs for managing RTIs. Topics covered will include opinions on primary care, attitudes toward using POCTs for RTIs, patient expectations, and how results should be communicated. Data management and analysis As per WP2, interviews will be audio and video recorded, transcribed verbatim using a transcription service, anonymised, and entered into NVivo ® . All transcripts will be analysed by the researcher (O’Shea), with a 20% random sample also reviewed by the Principal Investigator (Ryan) and PPI collaborator (Cooke). Patient transcripts will undergo thematic analysis, involving familiarisation, initial coding, grouping of codes into emerging themes, and assigning overarching themes. The analysis team will meet to discuss results, resolve any disagreements in interpretation, and review the findings with our PPI panel, ensuring all considerations are addressed when finalising the draft intervention(s) (see WP2 Development of the draft interventions for further details). WP4: Development of POCT intervention(s) with an expert task force to improve the management of RTIs in primary care The design of WP4 and WP5 will be informed by the findings from earlier work-packages, which will determine the structure of the proposed intervention. Depending on the outcomes of WP1 to WP3, the intervention may involve collaborative GP-CP practice, independent use within each setting, or a combination of both. Data analysis will distinguish between these models to identify the most effective approach, ensuring alignment with the practical needs of Irish primary care. Findings will be reported accordingly to provide clarity on implementation strategies. Draft interventions (developed following data analysis in WP2 and WP3) will be presented to task groups (see below) to obtain their views on the interventions, and to aid selection of the final intervention(s) for proof-of-concept testing. Task groups are a hybrid focus group intended to produce a set of principles for action grounded in task group members’ experiences and generate qualitative data 51 , 52 . This approach will ensure that the interventions are grounded in real world experiences of the healthcare professionals involved and ensure a patient-centred approach to the interventions adopted. The task group will be co-chaired by the researcher (O’Shea) and a PPI collaborator (Cooke). Non-jargonistic language will be used throughout, and all participants will receive a €100 honorarium for participation. Task group formulation and function A task group involving GPs, CPs, our PPI panel, and members of the team will be established. GPs (n = 2) and CPs (n = 2) will be recruited from those who participated in WP2. Patient and carer representatives will include our PPI panel (n = 3). Draft interventions derived from the findings of WP1 and WP2 will be identified and prioritised through discussions within the research team. These potential interventions will be presented to task group members (including our PPI panel) at a meeting dedicated to assessing their feasibility in terms of content and delivery. This evaluation will employ the APEASE criteria (Acceptability, Practicability, Effectiveness/cost-effectiveness, Affordability, Side-effects/safety, Equity), which were developed to guide context-based decisions on intervention content and delivery ( Table 1 ) 53 . Group discussions will be used to resolve discrepancies and reach agreement. Table 1. The APEASE criteria for assessing interventions, intervention components and ideas with example questions (adapted from 53 ). This table outlines the APEASE criteria (Affordability, Practicability, Effectiveness, Acceptability, Side-effects/safety, Equity), including example questions for applying these criteria during the assessment of interventions and their components. Adapted from reference 53 . APEASE criteria Example of potential questions A cceptability ▪ How far is it acceptable to key stakeholders? P racticability ▪ Can it be implemented at scale within the intended context, material and human resources? ▪ What would need to be done to ensure that the resources and personnel were in place, and is the intervention sustainable? E ffectiveness ▪ How effective is the intervention in achieving the policy objective(s)? ▪ How far will it reach the intended target group and how large an effect will it have on those who are reached? A ffordability ▪ How far can it be afforded when delivered at the scale intended? ▪ Can the necessary budget be found for it? ▪ Will it provide a good return on investment? S ide effects & safety ▪ What are the chances that it will lead to unintended adverse or beneficial outcomes? E quity ▪ How far will it increase or decrease differences between advantaged and disadvantaged sectors of society? Data management and analysis Detailed notes of the task group discussion will be taken by the researcher (O’Shea) and PI (Ryan). All feedback and suggestions put forth by task group members regarding the proposed intervention(s) will be carefully reviewed. Suggestions deemed unfeasible will be excluded from further consideration. A real-time summary and feedback on key discussion points will be provided to all task group members at the conclusion of the meeting. Subsequently, a comprehensive description of the newly developed intervention(s) will be drafted and circulated among the task group for final review and commentary. The research team will then meet online to reach a consensus on the final components of the intervention(s) that will advance to proof-of-concept testing (WP5). WP5: A proof-of-concept study to test the newly developed intervention(s) This WP will assess the proof-of-concept of the newly developed intervention(s) from WP4, depending on the findings from WP1-WP3. A separate protocol for the proof-of-concept study will be developed in accordance with the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) guidelines. Given the study's adaptive nature and its reliance on findings from previous WPs to shape the design, we cannot provide precise details of the study’s methodology at this stage. However, prior to patient enrolment, the proof-of-concept study will be registered in a WHO-recognised public repository to meet transparency and ethical standards. This approach ensures compliance with regulatory requirements, as recommended by the WHO International Clinical Trials Registry Platform (ICTRP) and the SPIRIT guidelines. A completed SPIRIT checklist will also be submitted to an online repository as extended data. It is anticipated that the newly developed intervention(s) will be tested in two settings (community pharmacy and general practice), recruited from the GPs and CPs involved in WP2. The researcher (O’Shea) will recruit and visit each site and present an overview of the POCT intervention(s). Training and patient information leaflets will be provided as required. To assess the fidelity of the newly developed intervention(s), it is likely that participating GPs and CPs will be requested to audio record their consultations with consenting patients, which will then be transcribed and content analysed. Descriptive analysis will be conducted on the collected data. Additionally, it is intended that all participating GPs, CPs, and patients will be invited to participate in semi-structured interviews to provide feedback on the newly developed intervention(s), highlighting what aspects worked well, areas for improvement, and suggested changes. The obtained data will be analysed descriptively and narratively, synthesised and presented to members of the team for further discussion and refinement of the intervention(s) approach. Discussion In light of antibiotic overprescribing and increasing antibiotic resistance, the development of an intervention(s) to improve the use of POCT(s) in the management of RTIs in primary care is critically important. This work describes the initial development phase of an evidence-based and theory-informed POCT intervention(s) to foster AMS in the management of RTIs considering the views and experiences of key stakeholders ( i.e., GPs, CPs and patients/carers) in ways that are effective and feasible in the Irish primary care setting. This study will identify how GPs and CPs can work together to successfully implement AMS, highlight the challenges of introducing POCT(s) in primary care, and develop best practice guidance for using POCT(s) in the management of RTIs. It will also identify barriers and facilitators to implementation, gather patient perspectives on POCT(s) use, analyse the behavioural changes required to improve its use, and ultimately design and test POCT intervention(s) for managing RTIs in Irish primary care. While this intervention development process will not explicitly include payer perspectives, future implementation will need to consider the role of reimbursement models and healthcare financing. The absence of structured funding for POCTs in Ireland could impact widespread adoption, making economic feasibility a key factor in policy discussions. This study could have the potential to optimise antibiotic prescribing, safeguard patients and prevent antibiotic resistance through collaborative antibiotic decision-making and care by GPs and CPs. Ethics and consent Ethical approval will be obtained for all studies from the School of Pharmacy & Pharmaceutical Sciences Research Ethics Committee, Trinity College Dublin, and the Irish College of General Practitioners, Dublin, for WP5. To date, ethical approval has been received for WP1, WP2, and WP3. Since the design of WP4 and WP5 will be shaped by the outcomes of the earlier work-packages, obtaining ethical approval for these components is not yet feasible. Once the relevant information becomes available, ethics applications for WP4 and WP5 will be promptly submitted. Study status WP1 – Approved by the School of Pharmacy & Pharmaceutical Sciences Research Ethics Committee, Trinity College Dublin. Currently finalising the analysis of Delphi questionnaire round 2. WP2 – Approved by the School of Pharmacy & Pharmaceutical Sciences Research Ethics Committee, Trinity College Dublin. WP3 – Approved by the School of Pharmacy & Pharmaceutical Sciences Research Ethics Committee, Trinity College Dublin. WP4 – The study design will be informed by the outcomes of WP1-3. Once the necessary data is available, an ethics application will be submitted promptly. WP5 – The study design will be informed by the outcomes of WP1-3. Once the necessary data is available, an ethics application will be submitted promptly. Consent statement All participants will be required to provide written informed consent prior to participation in the studies outlined in this protocol, confirming their understanding of each study's purpose, procedures, and any potential risks and benefits associated with their involvement. Data availability No data are associated with this article. Author contributions O’Shea J: Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Writing – Original Draft Preparation, Writing – Review & Editing; Hughes C: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing; Molloy G: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing; Cadogan C: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing; Vellinga A: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing; Fahey T: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing; Hayward G: Conceptualization, Methodology, Writing – Review & Editing; Ryan P: Conceptualization, Methodology, Writing – Review & Editing; Fleming A: Conceptualization, Methodology, Writing – Review & Editing; Morrissey E: Conceptualization, Methodology, Writing – Review & Editing; Cooke L: Methodology, Writing – Review & Editing; Ryan C: Conceptualization, Data Curation, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing Acknowledgements The authors would like to express thanks to our PPI panel for their anticipated support in developing the patient topic guides and for their advice on patient recruitment as part of the qualitative interview study. We would also like to express our sincere gratitude to Mala Shah (Chief Antimicrobial Pharmacist, Health Service Executive Community Operations) for her invaluable support in developing the best practice guidance and for her anticipated review of the healthcare professional topic guides. Faculty Opinions recommended References 1. Coque TM, Graham DW, Pruden A, et al. : Bracing for superbugs. strengthening environmental action in the one health response to Antimicrobial Resistance. United Nations Environment Programme, 2023. Reference Source 2. World Health Organisation: Antimicrobial Resistance. Global report on surveillance. 2014; Accessed 04.06.24. Reference Source 3. van der Velden AW, van de Pol AC, Bongard E, et al. : Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countries. BJGP Open. 2022; 6 (2): BJGPO.2021.0212. PubMed Abstract | Publisher Full Text | Free Full Text 4. Antimicrobial consumption in the EU/EEA (ESAC-Net). Annual Epidemiological Report for 2022. European Centre for Disease Prevention and Control, 2023. Reference Source 5. Dekker ARJ, Verheij TJM, van der Velden AW: Inappropriate antibiotic prescription for Respiratory Tract Indications: most prominent in adult patients. Fam Pract. 2015; 32 (4): 401–7. PubMed Abstract | Publisher Full Text 6. McCullough AR, Pollack AJ, Plejdrup Hansen M, et al. : Antibiotics for Acute Respiratory Infections in general practice: comparison of prescribing rates with guideline recommendations. Med J Aust. 2017; 207 (2): 65–69. PubMed Abstract | Publisher Full Text 7. Tonkin-Crine SKG, Tan PS, van Hecke O, et al. : Clinician-targeted interventions to influence antibiotic prescribing behaviour for Acute Respiratory Infections in primary care: an overview of systematic reviews. Cochrane Database Syst Rev. 2017; 9 (9): CD012252. PubMed Abstract | Publisher Full Text | Free Full Text 8. Pouwels KB, Dolk FCK, Smith DRM, et al. : Actual versus ‘ideal’ antibiotic prescribing for common conditions in English primary care. J Antimicrob Chemother. 2018; 73 (suppl_ 2): 19–26. PubMed Abstract | Publisher Full Text | Free Full Text 9. Cooke J, Llor C, Hopstaken R, et al. : Respiratory Tract Infections (RTIs) in primary care: narrative review of C Reactive Protein (CRP) Point-Of-Care Testing (POCT) and antibacterial use in patients who present with symptoms of RTI. BMJ Open Respir Res. 2020; 7 (1): e000624. PubMed Abstract | Publisher Full Text | Free Full Text 10. Gentile I, Schiano Moriello N, Hopstaken R, et al. : The role of CRP POC testing in the fight against antibiotic overuse in European primary care: recommendations from a European expert panel. Diagnostics (Basel). 2023; 13 (2): 320. PubMed Abstract | Publisher Full Text | Free Full Text 11. Bishop C, Yacoob Z, Knobloch MJ, et al. : Community pharmacy interventions to improve antibiotic stewardship and implications for pharmacy education: a narrative overview. Res Social Adm Pharm. 2019; 15 (6): 627–631. PubMed Abstract | Publisher Full Text 12. Saha SK, Kong DCM, Thursky K, et al. : Development of an antimicrobial stewardship implementation model involving collaboration between general practitioners and pharmacists: GPPAS study in Australian primary care. Prim Health Care Res Dev. 2021; 22 : e2. PubMed Abstract | Publisher Full Text | Free Full Text 13. Saha SK, Hawes L, Mazza D: Effectiveness of interventions involving pharmacists on antibiotic prescribing by General Practitioners: a systematic review and meta-analysis. J Antimicrob Chemother. 2019; 74 (5): 1173–81. PubMed Abstract | Publisher Full Text 14. Rawlinson C, Carron T, Cohidon C, et al. : An overview of reviews on Interprofessional Collaboration in primary care: barriers and facilitators. Int J Integr Care. 2021; 21 (2): 32. PubMed Abstract | Publisher Full Text | Free Full Text 15. Stuart B, Hounkpatin H, Becque T, et al. : Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ. 2021; 373 : n808. PubMed Abstract | Publisher Full Text | Free Full Text 16. Arnold S, Straus S: Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev. 2005; 2005 (4): CD003539. PubMed Abstract | Publisher Full Text | Free Full Text 17. Butler CC, Simpson SA, Dunstan F, et al. : Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ. 2012; 344 : d8173. PubMed Abstract | Publisher Full Text | Free Full Text 18. Cals JWL, Butler CC, Hopstaken RM, et al. : Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ. 2009; 338 : b1374. PubMed Abstract | Publisher Full Text | Free Full Text 19. Little P, Stuart B, Francis N, et al. : Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet. 2013; 382 (9899): 1175–82. PubMed Abstract | Publisher Full Text | Free Full Text 20. van der Velden AW, Pijpers EJ, Kuyvenhoven MM, et al. : Effectiveness of physician-targeted interventions to improve antibiotic use for Respiratory Tract Infections. Br J Gen Pract. 2012; 62 (605): e801. PubMed Abstract | Publisher Full Text | Free Full Text 21. Mustafa Z, Ghaffari M: Diagnostic methods, clinical guidelines, and antibiotic treatment for Group A streptococcal pharyngitis: a narrative review. Front Cell Infect Microbiol. 2020; 10 : 563627. PubMed Abstract | Publisher Full Text | Free Full Text 22. Lean WL, Arnup S, Danchin M, et al. : Rapid diagnostic tests for Group A Streptococcal pharyngitis: a meta-analysis. Pediatrics. 2014; 134 (4): 771–81. PubMed Abstract | Publisher Full Text 23. Cooke J, Butler C, Hopstaken R, et al. : Narrative review of primary care Point-Of-Care Testing (POCT) and antibacterial use in Respiratory Tract Infection (RTI). BMJ Open Respir Res. 2015; 2 (1): e000086. PubMed Abstract | Publisher Full Text | Free Full Text 24. Chambliss AB, Patel K, Colón-Franco JM, et al. : AACC guidance document on the clinical use of Procalcitonin. J Appl Lab Med. 2023; 8 (3): 598–634. PubMed Abstract | Publisher Full Text 25. Fawsitt CG, Lucey D, Harrington P, et al. : A cost-effectiveness and budget impact analysis of C-Reactive Protein Point-Of-Care Testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings in Ireland: a decision-analytic model. Family Practice. 2022; 39 (3): 389–397. PubMed Abstract | Publisher Full Text 26. Atkins L, Francis J, Islam R, et al. : A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci. 2017; 12 (1): 77. PubMed Abstract | Publisher Full Text | Free Full Text 27. Cole J, Hughes C, Cadogan C, et al. : Evidence for using point-of-care diagnostics in the management of Respiratory Tract Infections in primary care: a scoping review protocol [version 1; peer review: 2 approved]. HRB Open Res. 2023; 59 (6): 59. PubMed Abstract | Publisher Full Text | Free Full Text 28. Brouwers MC, Kho ME, Browman GP, et al. : AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010; 182 (18): E839–42. PubMed Abstract | Publisher Full Text | Free Full Text 29. Hsu CC, Sandford BA: The Delphi technique: making sense of consensus. Pract Assess Res Eval. 2007; 12 : 10. Publisher Full Text 30. Campbell SM, Cantrill JA: Consensus methods in prescribing research. J Clin Pharm Ther. 2001; 26 (1): 5–14. PubMed Abstract 31. Hasson F, Keeney S, McKenna H: Research guidelines for the Delphi survey technique. J Adv Nurs. 2000; 32 (4): 1008–15. PubMed Abstract | Publisher Full Text 32. Qualtrics, Provo, Utah, USA: First release: 2005. Version: May 2024. Acessed 01.05.24. Reference Source 33. Cooper JA, Ryan C, Smith SM, et al. : The development of the PROMPT (PRescribing Optimally in Middle-aged People’s Treatments) criteria. BMC Health Serv Res. 2014; 14 (1): 484. PubMed Abstract | Publisher Full Text | Free Full Text 34. Tong A, Sainsbury P, Craig J: Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19 (6): 349–57. PubMed Abstract | Publisher Full Text 35. Patton DE, Ryan C, Hughes CM: Enhancing community pharmacists’ provision of Medication Adherence Support to older adults: a mixed methods study using the Theoretical Domains Framework. Res Social Adm Pharm. 2021; 17 (2): 406–18. PubMed Abstract | Publisher Full Text 36. Rankin A, Cadogan CA, Barry HE, et al. : An external pilot Cluster Randomised Controlled Trial of a theory-based intervention to improve appropriate polypharmacy in older people in primary care (PolyPrime): study protocol. Pilot Feasibility Stud. 2021; 7 (1): 77. PubMed Abstract | Publisher Full Text | Free Full Text 37. McCullough AR, Ryan C, O’Neill B, et al. : Defining the content and delivery of an intervention to Change AdhereNce to treatment in BonchiEctasis (CAN-BE): a qualitative approach incorporating the Theoretical Domains Framework, Behavioural Change Techniques and stakeholder expert panels. BMC Health Serv Res. 2015; 15 (1): 342. PubMed Abstract | Publisher Full Text | Free Full Text 38. Barry HE, Bedford LE, McGrattan M, et al. : Improving medicines management for People with Dementia in primary care: a qualitative study of healthcare professionals to develop a theory-informed intervention. BMC Health Serv Res. 2020; 20 (1): 120. PubMed Abstract | Publisher Full Text | Free Full Text 39. Eley CV, Sharma A, Lecky DM, et al. : Qualitative study to explore the views of general practice staff on the use of point-of-care C Reactive Protein testing for the management of lower Respiratory Tract Infections in routine general practice in England. BMJ Open. 2018; 8 (10): e023925. PubMed Abstract | Publisher Full Text | Free Full Text 40. National Institute for Health and Care Excellence (NICE): Pneumonia: diagnosis and management of community- and hospital-acquired pneumonia in adults. NICE, London, 2014; Accessed 16.02.24. PubMed Abstract 41. Hardy V, Thompson M, Keppel GA, et al. : Qualitative study of primary care clinicians’ views on Point-Of-Care Testing for C-Reactive Protein for acute Respiratory Tract Infections in family medicine. BMJ Open. 2017; 7 (1): e012503. PubMed Abstract | Publisher Full Text | Free Full Text 42. QSR International Pty Ltd: NVivo (Version 12). [Computer software], 2018; Access 05.09.24. Reference Source 43. Gale NK, Heath G, Cameron E, et al. : Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013; 13 (1): 117. PubMed Abstract | Publisher Full Text | Free Full Text 44. Marques MM, Wright AJ, Corker E, et al. : The Behaviour Change Technique Ontology: transforming the Behaviour Change Technique Taxonomy v1 [version 1; peer review: 4 approved]. Wellcome Open Res. 2024; 8 : 308. PubMed Abstract | Publisher Full Text | Free Full Text 45. Cane J, Richardson M, Johnston M, et al. : From lists of Behaviour Change Techniques (BCTs) to structured hierarchies: comparison of two methods of developing a hierarchy of BCTs. Br J Health Psychol. 2015; 20 (1): 130–50. PubMed Abstract | Publisher Full Text 46. Michie S, Johnston M, Francis J, et al. : From theory to intervention: mapping theoretically derived behavioural determinants to Behaviour Change Techniques. Appl Psychol. 2008; 57 (4): 660–80. Publisher Full Text 47. Malterud K, Siersma VD, Guassora AD: Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016; 26 (13): 1753–60. PubMed Abstract | Publisher Full Text 48. Huddy JR, Ni MZ, Barlow J, et al. : Qualitative analysis of stakeholder interviews to identify the barriers and facilitators to the adoption of point-of-care diagnostic tests in the UK. BMJ Open. 2021; 11 (4): e042944. PubMed Abstract | Publisher Full Text | Free Full Text 49. Pai NP, Wilkinson S, Deli-Houssein R, et al. : Barriers to implementation of rapid and Point-of-Care Tests for Human Immunodeficiency Virus infection: findings from a systematic review (1996–2014). Point Care. 2015; 14 (3): 81–87. PubMed Abstract | Publisher Full Text | Free Full Text 50. Yonel Z, Yahyouche A, Jalal Z, et al. : Patient acceptability of targeted risk-based detection of non-communicable diseases in a dental and pharmacy setting. BMC Public Health. 2020; 20 (1): 1576. PubMed Abstract | Publisher Full Text | Free Full Text 51. Mort M, Finch T: Principles for telemedicine and telecare: the perspective of a citizens' panel. J Telemed Telecare. 2005; 11 Suppl 1 : 66–8. PubMed Abstract | Publisher Full Text 52. May CR, Finch TL, Cornford J, et al. : Integrating telecare for chronic disease management in the community: what needs to be done? BMC Health Serv Res. 2011; 11 (1): 131. PubMed Abstract | Publisher Full Text | Free Full Text 53. Public Health England: Achieving behaviour change: a guide for local government and partners. Accessed 14.05.24. Reference Source Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 20 Nov 2024 ADD YOUR COMMENT Comment Author details Author details 1 School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Leinster, Ireland 2 School of Pharmacy, Queen's University Belfast, Belfast, Northern Ireland, UK 3 School of Psychology, College of Arts, Social Sciences and Celtic Studies, University of Galway, Galway, County Galway, Ireland 4 School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland 5 Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland 6 Department of Primary Care Health Sciences, University of Oxford, Oxford, England, UK 7 Irish College of General Practitioners, Dublin, Ireland 8 School of Pharmacy, University College Cork, Cork, Ireland 9 Centre for Health Research Methodology, School of Nursing and Midwifery, University of Galway, Galway, Ireland 10 Institute for Clinical Trials, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland 11 The Irish Platform for Patient Organisations, Science, and Industry (IPPOSI), Dublin, Ireland Joseph O'Shea Roles: Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Writing – Original Draft Preparation, Writing – Review & Editing Carmel Hughes Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Gerard Molloy Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Cathal Cadogan Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Akke Vellinga Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Tom Fahey Roles: Conceptualization, Funding Acquisition, Investigation, Methodology, Writing – Review & Editing Gail Hayward Roles: Conceptualization, Methodology, Writing – Review & Editing Paul Ryan Roles: Conceptualization, Methodology, Writing – Review & Editing Aoife Fleming Roles: Conceptualization, Methodology, Writing – Review & Editing Eimear Morrissey Roles: Conceptualization, Methodology, Writing – Review & Editing Laura Cooke Roles: Methodology, Writing – Review & Editing Cristin Ryan Roles: Conceptualization, Data Curation, Funding Acquisition, Investigation, Methodology, Project Administration, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information Health Research Board [ILP-HSR-2022-006].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Article Versions (2) version 2 Revised Published: 07 Mar 2025, 7:73 https://doi.org/10.12688/hrbopenres.13962.2 version 1 Published: 20 Nov 2024, 7:73 https://doi.org/10.12688/hrbopenres.13962.1 Copyright © 2025 O'Shea J et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics VIEWS $counts.viewCount downloads Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article O'Shea J, Hughes C, Molloy G et al. Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.12688/hrbopenres.13962.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 2 VERSION 2 PUBLISHED 07 Mar 2025 Revised Views 0 Cite How to cite this report: Saha S. Reviewer Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15500.r46333 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v2#referee-response-46333 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 11 Mar 2025 Sajal Saha , Deakin University, Geelong, Australia Approved VIEWS 0 https://doi.org/10.21956/hrbopenres.15500.r46333 The authors have ... Continue reading READ ALL The authors have addressed the comments. Competing Interests: No competing interests were disclosed. Reviewer Expertise: antibiotic stewardship in primary care, GP-pharmacist care model, point-of-care testing I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Saha S. Reviewer Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15500.r46333 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v2#referee-response-46333 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Schmiemann G. Reviewer Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15500.r46334 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v2#referee-response-46334 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 08 Mar 2025 Guido Schmiemann , University of Bremen, Bremen, Germany Approved VIEWS 0 https://doi.org/10.21956/hrbopenres.15500.r46334 Thanks for the changes made. All my comments have ... Continue reading READ ALL Thanks for the changes made. All my comments have been taken into account and I have no further remarks. Competing Interests: No competing interests were disclosed. Reviewer Expertise: GP with experience in guideline development, health services research I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Schmiemann G. Reviewer Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15500.r46334 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v2#referee-response-46334 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Version 1 VERSION 1 PUBLISHED 20 Nov 2024 Views 0 Cite How to cite this report: Saha S. Reviewer Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15318.r43347 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v1#referee-response-43347 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 27 Dec 2024 Sajal Saha , Deakin University, Geelong, Australia Approved VIEWS 0 https://doi.org/10.21956/hrbopenres.15318.r43347 The PREDICTORS study seems novel in Irish primary care that develops and tests an intervention to improve the use of POCTs in RTIs by GPs and CPs. The study protocol has considered scientifically sound and robust methodologies for the development ... Continue reading READ ALL The PREDICTORS study seems novel in Irish primary care that develops and tests an intervention to improve the use of POCTs in RTIs by GPs and CPs. The study protocol has considered scientifically sound and robust methodologies for the development of the intervention. There is only one area of concern to me. The POCT implementation model remains unclear. Is the intervention development driven by GP-pharmacist collaborative implementation of POCT testing or POCT use separately in GP and pharmacy settings or both? How would author interpret, use and report those data in terms of the settings? Whether the guideline that will be developed would be specific to settings (GP/pharmacy) or implementation model or in general?. A clear reporting may enhance clarity and understanding of the development and testing. Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Not applicable Competing Interests: No competing interests were disclosed. Reviewer Expertise: antibiotic stewardship in primary care, GP-pharmacist care model, point-of-care testing I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Saha S. Reviewer Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15318.r43347 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v1#referee-response-43347 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 07 Mar 2025 Joseph O'Shea , School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland 07 Mar 2025 Author Response Dear Dr Saha, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your ... Continue reading Dear Dr Saha, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: Clarify whether the intervention focuses on GP-CP collaboration, independent POCT use in each setting, or both. State explicitly how data will be analyzed and reported based on the setting. Clarify whether the developed guidelines will be setting-specific (GP/pharmacy) or generalizable across both settings. These have been addressed. The description of the POCT implementation model now acknowledges that WP4 and WP5 will be shaped by earlier findings, allowing for a range of potential intervention models, including collaborative or independent GP-CP practice. The guideline specificity section has been updated to reflect that the Delphi study will determine where and by whom POCT should be used, with the final guidance incorporating only consensus-based statements while maintaining POCT-specific recommendations. Kind regards, Dr Joseph O'Shea Dear Dr Saha, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: Clarify whether the intervention focuses on GP-CP collaboration, independent POCT use in each setting, or both. State explicitly how data will be analyzed and reported based on the setting. Clarify whether the developed guidelines will be setting-specific (GP/pharmacy) or generalizable across both settings. These have been addressed. The description of the POCT implementation model now acknowledges that WP4 and WP5 will be shaped by earlier findings, allowing for a range of potential intervention models, including collaborative or independent GP-CP practice. The guideline specificity section has been updated to reflect that the Delphi study will determine where and by whom POCT should be used, with the final guidance incorporating only consensus-based statements while maintaining POCT-specific recommendations. Kind regards, Dr Joseph O'Shea Competing Interests: No competing interests were disclosed. Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 07 Mar 2025 Joseph O'Shea , School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland 07 Mar 2025 Author Response Dear Dr Saha, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your ... Continue reading Dear Dr Saha, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: Clarify whether the intervention focuses on GP-CP collaboration, independent POCT use in each setting, or both. State explicitly how data will be analyzed and reported based on the setting. Clarify whether the developed guidelines will be setting-specific (GP/pharmacy) or generalizable across both settings. These have been addressed. The description of the POCT implementation model now acknowledges that WP4 and WP5 will be shaped by earlier findings, allowing for a range of potential intervention models, including collaborative or independent GP-CP practice. The guideline specificity section has been updated to reflect that the Delphi study will determine where and by whom POCT should be used, with the final guidance incorporating only consensus-based statements while maintaining POCT-specific recommendations. Kind regards, Dr Joseph O'Shea Dear Dr Saha, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: Clarify whether the intervention focuses on GP-CP collaboration, independent POCT use in each setting, or both. State explicitly how data will be analyzed and reported based on the setting. Clarify whether the developed guidelines will be setting-specific (GP/pharmacy) or generalizable across both settings. These have been addressed. The description of the POCT implementation model now acknowledges that WP4 and WP5 will be shaped by earlier findings, allowing for a range of potential intervention models, including collaborative or independent GP-CP practice. The guideline specificity section has been updated to reflect that the Delphi study will determine where and by whom POCT should be used, with the final guidance incorporating only consensus-based statements while maintaining POCT-specific recommendations. Kind regards, Dr Joseph O'Shea Competing Interests: No competing interests were disclosed. Close Report a concern COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Schmiemann G. Reviewer Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15318.r43345 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v1#referee-response-43345 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 02 Dec 2024 Guido Schmiemann , University of Bremen, Bremen, Germany Approved with Reservations VIEWS 0 https://doi.org/10.21956/hrbopenres.15318.r43345 Review of the PREDICTORS Study Protocol Thank you for the opportunity to review the study protocol of the PREDICTORS study. The study aims to develop and test an intervention designed to enhance the antibiotic prescribing process for respiratory tract ... Continue reading READ ALL Review of the PREDICTORS Study Protocol Thank you for the opportunity to review the study protocol of the PREDICTORS study. The study aims to develop and test an intervention designed to enhance the antibiotic prescribing process for respiratory tract infections using point-of-care tests (POCT). Influencing the antibiotic prescribing process is a complex intervention; accordingly, the proposed study encompasses multiple aims. These aims address various perspectives, and the development of a new intervention is grounded in theoretical models suited for the study's objectives. Overall, the objectives, proposed aims, and methods are well articulated, resulting in a scientifically sound description. Since the study has already commenced and changes to the process may no longer be feasible, my suggestions primarily focus on enhancing the discussion and presentation of the results. Background: I recommend providing context for the study by including information on prescribing rates in Ireland, which are slightly above the EU average ( https://www.ecdc.europa.eu/sites/default/files/documents/AER-antimicrobial-consumption.pdf ). While some point-of-care tests are mentioned, the authors might consider elaborating on which POCTs are currently approved or used in primary care settings in Ireland. It appears that economic aspects are not addressed in the study or the proof-of-concept phase. Given the existing evidence regarding CRP tests in Ireland (Fawsitt CG. et al, 2022 [Ref-1]), this information could strengthen the background or discussion sections. Methods: To develop best practice guidance for utilizing POCTs in managing RTIs in primary care, a scoping review that assesses the literature will be employed. I suggest also searching for grey literature, including projects already conducted in various healthcare systems in Ireland, as they may reveal valuable lessons not captured within the published literature. When recruiting participating GPs and Community Pharmacists (CPs), gender is mentioned as a potential influencing factor. It would be beneficial to consider additional factors, such as age and urban versus rural settings, as they may impact familiarity with or accessibility to POCTs. The study plans to assess patient perspectives through qualitative interviews. The content analysis of these interviews will be conducted by one researcher, with a random sample reviewed by a second researcher. Please clarify whether thematic analysis, coding, etc., will solely be performed by the primary researcher. The protocol mentions an analysis team; how does their role influence the final coding process? Is the final coding completed only after the analysis team has consented to the coding framework? Additional clarity on this process would be appreciated. Discussion: In discussing the development of the intervention, it is important to consider the role of payers in the success of any future intervention. Are payer perspectives incorporated into the development of the intervention? Understanding this aspect could be crucial for addressing the needs and dynamics of the Irish healthcare system. Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Partly Are the datasets clearly presented in a useable and accessible format? Not applicable References 1. Fawsitt CG, Lucey D, Harrington P, Jordan K, et al.: A cost-effectiveness and budget impact analysis of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings in Ireland: a decision-analytic model. Fam Pract . 2022; 39 (3): 389-397 PubMed Abstract | Publisher Full Text Competing Interests: No competing interests were disclosed. Reviewer Expertise: GP with experience in guideline development, health services research I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Schmiemann G. Reviewer Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15318.r43345 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v1#referee-response-43345 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 07 Mar 2025 Joseph O'Shea , School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland 07 Mar 2025 Author Response Dear Dr Schmiemann, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your ... Continue reading Dear Dr Schmiemann, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: 1. Background: Prescribing Rates in Ireland: Add a sentence referencing the ECDC report on Ireland’s antibiotic prescribing rates being slightly above the EU average. Explain how this context supports the need for interventions like POCT. Approved POCTs in Irish Primary Care: Expand the section on POCTs to clarify which ones are currently approved or used in primary care in Ireland. Economic Considerations: Acknowledge that economic factors are not the primary focus of this study but reference existing research (e.g., Fawsitt et al., 2022) in the discussion to highlight the economic feasibility of CRP POCTs in Ireland. 2. Methods: Grey Literature in Scoping Review: Add a statement that grey literature, including national projects and reports, will be reviewed alongside peer-reviewed literature. Recruitment Factors Beyond Gender: Clarify that in addition to gender, recruitment will aim for diversity in age and urban/rural practice settings. Clarification on Qualitative Analysis: Explicitly state whether thematic analysis will be conducted solely by the primary researcher or in collaboration with the analysis team. Explain the role of the analysis team in reviewing, refining, and finalizing the coding framework. 3. Discussion: Role of Payers in Intervention Development: Acknowledge that payer perspectives were not explicitly included but discuss how reimbursement models and healthcare system factors could influence future implementation. These have been addressed. The background section now includes details on antibiotic prescribing rates in Ireland and expands on existing POCTs commonly used in Irish primary care. The economic considerations section has been refined to summarize key findings from Fawsitt et al., emphasizing the cost-effectiveness and budget impact of CRP POCT implementation. In the methods section, we have clarified that grey literature will be reviewed alongside peer-reviewed sources in the scoping review. Recruitment criteria have been expanded to consider additional demographic factors, such as age and urban versus rural practice settings, to ensure a diverse participant sample. Further clarification has been added regarding qualitative data analysis, specifying the roles of the primary researcher and analysis team in coding and validation. The discussion has been revised to address the role of payers in intervention implementation, noting potential reimbursement challenges. These updates enhance the clarity and completeness of the protocol, ensuring alignment with the study's aims and the practical considerations of POCT implementation in Irish primary care. Kind regards, Dr Joseph O'Shea Dear Dr Schmiemann, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: 1. Background: Prescribing Rates in Ireland: Add a sentence referencing the ECDC report on Ireland’s antibiotic prescribing rates being slightly above the EU average. Explain how this context supports the need for interventions like POCT. Approved POCTs in Irish Primary Care: Expand the section on POCTs to clarify which ones are currently approved or used in primary care in Ireland. Economic Considerations: Acknowledge that economic factors are not the primary focus of this study but reference existing research (e.g., Fawsitt et al., 2022) in the discussion to highlight the economic feasibility of CRP POCTs in Ireland. 2. Methods: Grey Literature in Scoping Review: Add a statement that grey literature, including national projects and reports, will be reviewed alongside peer-reviewed literature. Recruitment Factors Beyond Gender: Clarify that in addition to gender, recruitment will aim for diversity in age and urban/rural practice settings. Clarification on Qualitative Analysis: Explicitly state whether thematic analysis will be conducted solely by the primary researcher or in collaboration with the analysis team. Explain the role of the analysis team in reviewing, refining, and finalizing the coding framework. 3. Discussion: Role of Payers in Intervention Development: Acknowledge that payer perspectives were not explicitly included but discuss how reimbursement models and healthcare system factors could influence future implementation. These have been addressed. The background section now includes details on antibiotic prescribing rates in Ireland and expands on existing POCTs commonly used in Irish primary care. The economic considerations section has been refined to summarize key findings from Fawsitt et al., emphasizing the cost-effectiveness and budget impact of CRP POCT implementation. In the methods section, we have clarified that grey literature will be reviewed alongside peer-reviewed sources in the scoping review. Recruitment criteria have been expanded to consider additional demographic factors, such as age and urban versus rural practice settings, to ensure a diverse participant sample. Further clarification has been added regarding qualitative data analysis, specifying the roles of the primary researcher and analysis team in coding and validation. The discussion has been revised to address the role of payers in intervention implementation, noting potential reimbursement challenges. These updates enhance the clarity and completeness of the protocol, ensuring alignment with the study's aims and the practical considerations of POCT implementation in Irish primary care. Kind regards, Dr Joseph O'Shea Competing Interests: No competing interests were disclosed. Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 07 Mar 2025 Joseph O'Shea , School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland 07 Mar 2025 Author Response Dear Dr Schmiemann, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your ... Continue reading Dear Dr Schmiemann, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: 1. Background: Prescribing Rates in Ireland: Add a sentence referencing the ECDC report on Ireland’s antibiotic prescribing rates being slightly above the EU average. Explain how this context supports the need for interventions like POCT. Approved POCTs in Irish Primary Care: Expand the section on POCTs to clarify which ones are currently approved or used in primary care in Ireland. Economic Considerations: Acknowledge that economic factors are not the primary focus of this study but reference existing research (e.g., Fawsitt et al., 2022) in the discussion to highlight the economic feasibility of CRP POCTs in Ireland. 2. Methods: Grey Literature in Scoping Review: Add a statement that grey literature, including national projects and reports, will be reviewed alongside peer-reviewed literature. Recruitment Factors Beyond Gender: Clarify that in addition to gender, recruitment will aim for diversity in age and urban/rural practice settings. Clarification on Qualitative Analysis: Explicitly state whether thematic analysis will be conducted solely by the primary researcher or in collaboration with the analysis team. Explain the role of the analysis team in reviewing, refining, and finalizing the coding framework. 3. Discussion: Role of Payers in Intervention Development: Acknowledge that payer perspectives were not explicitly included but discuss how reimbursement models and healthcare system factors could influence future implementation. These have been addressed. The background section now includes details on antibiotic prescribing rates in Ireland and expands on existing POCTs commonly used in Irish primary care. The economic considerations section has been refined to summarize key findings from Fawsitt et al., emphasizing the cost-effectiveness and budget impact of CRP POCT implementation. In the methods section, we have clarified that grey literature will be reviewed alongside peer-reviewed sources in the scoping review. Recruitment criteria have been expanded to consider additional demographic factors, such as age and urban versus rural practice settings, to ensure a diverse participant sample. Further clarification has been added regarding qualitative data analysis, specifying the roles of the primary researcher and analysis team in coding and validation. The discussion has been revised to address the role of payers in intervention implementation, noting potential reimbursement challenges. These updates enhance the clarity and completeness of the protocol, ensuring alignment with the study's aims and the practical considerations of POCT implementation in Irish primary care. Kind regards, Dr Joseph O'Shea Dear Dr Schmiemann, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: 1. Background: Prescribing Rates in Ireland: Add a sentence referencing the ECDC report on Ireland’s antibiotic prescribing rates being slightly above the EU average. Explain how this context supports the need for interventions like POCT. Approved POCTs in Irish Primary Care: Expand the section on POCTs to clarify which ones are currently approved or used in primary care in Ireland. Economic Considerations: Acknowledge that economic factors are not the primary focus of this study but reference existing research (e.g., Fawsitt et al., 2022) in the discussion to highlight the economic feasibility of CRP POCTs in Ireland. 2. Methods: Grey Literature in Scoping Review: Add a statement that grey literature, including national projects and reports, will be reviewed alongside peer-reviewed literature. Recruitment Factors Beyond Gender: Clarify that in addition to gender, recruitment will aim for diversity in age and urban/rural practice settings. Clarification on Qualitative Analysis: Explicitly state whether thematic analysis will be conducted solely by the primary researcher or in collaboration with the analysis team. Explain the role of the analysis team in reviewing, refining, and finalizing the coding framework. 3. Discussion: Role of Payers in Intervention Development: Acknowledge that payer perspectives were not explicitly included but discuss how reimbursement models and healthcare system factors could influence future implementation. These have been addressed. The background section now includes details on antibiotic prescribing rates in Ireland and expands on existing POCTs commonly used in Irish primary care. The economic considerations section has been refined to summarize key findings from Fawsitt et al., emphasizing the cost-effectiveness and budget impact of CRP POCT implementation. In the methods section, we have clarified that grey literature will be reviewed alongside peer-reviewed sources in the scoping review. Recruitment criteria have been expanded to consider additional demographic factors, such as age and urban versus rural practice settings, to ensure a diverse participant sample. Further clarification has been added regarding qualitative data analysis, specifying the roles of the primary researcher and analysis team in coding and validation. The discussion has been revised to address the role of payers in intervention implementation, noting potential reimbursement challenges. These updates enhance the clarity and completeness of the protocol, ensuring alignment with the study's aims and the practical considerations of POCT implementation in Irish primary care. Kind regards, Dr Joseph O'Shea Competing Interests: No competing interests were disclosed. Close Report a concern COMMENT ON THIS REPORT Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 20 Nov 2024 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 Version 2 (revision) 07 Mar 25 read read Version 1 20 Nov 24 read read Guido Schmiemann , University of Bremen, Bremen, Germany Sajal Saha , Deakin University, Geelong, Australia Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2025 Saha S. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 11 Mar 2025 | for Version 2 Sajal Saha , Deakin University, Geelong, Australia 0 Views copyright © 2025 Saha S. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The authors have addressed the comments. Competing Interests No competing interests were disclosed. Reviewer Expertise antibiotic stewardship in primary care, GP-pharmacist care model, point-of-care testing I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Saha S. Peer Review Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15500.r46333) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v2#referee-response-46333 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2025 Schmiemann G. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 08 Mar 2025 | for Version 2 Guido Schmiemann , University of Bremen, Bremen, Germany 0 Views copyright © 2025 Schmiemann G. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Thanks for the changes made. All my comments have been taken into account and I have no further remarks. Competing Interests No competing interests were disclosed. Reviewer Expertise GP with experience in guideline development, health services research I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Schmiemann G. Peer Review Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15500.r46334) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v2#referee-response-46334 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Saha S. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 27 Dec 2024 | for Version 1 Sajal Saha , Deakin University, Geelong, Australia 0 Views copyright © 2024 Saha S. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions The PREDICTORS study seems novel in Irish primary care that develops and tests an intervention to improve the use of POCTs in RTIs by GPs and CPs. The study protocol has considered scientifically sound and robust methodologies for the development of the intervention. There is only one area of concern to me. The POCT implementation model remains unclear. Is the intervention development driven by GP-pharmacist collaborative implementation of POCT testing or POCT use separately in GP and pharmacy settings or both? How would author interpret, use and report those data in terms of the settings? Whether the guideline that will be developed would be specific to settings (GP/pharmacy) or implementation model or in general?. A clear reporting may enhance clarity and understanding of the development and testing. Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Not applicable Competing Interests No competing interests were disclosed. Reviewer Expertise antibiotic stewardship in primary care, GP-pharmacist care model, point-of-care testing I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (1) Author Response 07 Mar 2025 Joseph O'Shea, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland Dear Dr Saha, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: Clarify whether the intervention focuses on GP-CP collaboration, independent POCT use in each setting, or both. State explicitly how data will be analyzed and reported based on the setting. Clarify whether the developed guidelines will be setting-specific (GP/pharmacy) or generalizable across both settings. These have been addressed. The description of the POCT implementation model now acknowledges that WP4 and WP5 will be shaped by earlier findings, allowing for a range of potential intervention models, including collaborative or independent GP-CP practice. The guideline specificity section has been updated to reflect that the Delphi study will determine where and by whom POCT should be used, with the final guidance incorporating only consensus-based statements while maintaining POCT-specific recommendations. Kind regards, Dr Joseph O'Shea View more View less Competing Interests No competing interests were disclosed. reply Respond Report a concern Saha S. Peer Review Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15318.r43347) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v1#referee-response-43347 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Schmiemann G. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 02 Dec 2024 | for Version 1 Guido Schmiemann , University of Bremen, Bremen, Germany 0 Views copyright © 2024 Schmiemann G. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Review of the PREDICTORS Study Protocol Thank you for the opportunity to review the study protocol of the PREDICTORS study. The study aims to develop and test an intervention designed to enhance the antibiotic prescribing process for respiratory tract infections using point-of-care tests (POCT). Influencing the antibiotic prescribing process is a complex intervention; accordingly, the proposed study encompasses multiple aims. These aims address various perspectives, and the development of a new intervention is grounded in theoretical models suited for the study's objectives. Overall, the objectives, proposed aims, and methods are well articulated, resulting in a scientifically sound description. Since the study has already commenced and changes to the process may no longer be feasible, my suggestions primarily focus on enhancing the discussion and presentation of the results. Background: I recommend providing context for the study by including information on prescribing rates in Ireland, which are slightly above the EU average ( https://www.ecdc.europa.eu/sites/default/files/documents/AER-antimicrobial-consumption.pdf ). While some point-of-care tests are mentioned, the authors might consider elaborating on which POCTs are currently approved or used in primary care settings in Ireland. It appears that economic aspects are not addressed in the study or the proof-of-concept phase. Given the existing evidence regarding CRP tests in Ireland (Fawsitt CG. et al, 2022 [Ref-1]), this information could strengthen the background or discussion sections. Methods: To develop best practice guidance for utilizing POCTs in managing RTIs in primary care, a scoping review that assesses the literature will be employed. I suggest also searching for grey literature, including projects already conducted in various healthcare systems in Ireland, as they may reveal valuable lessons not captured within the published literature. When recruiting participating GPs and Community Pharmacists (CPs), gender is mentioned as a potential influencing factor. It would be beneficial to consider additional factors, such as age and urban versus rural settings, as they may impact familiarity with or accessibility to POCTs. The study plans to assess patient perspectives through qualitative interviews. The content analysis of these interviews will be conducted by one researcher, with a random sample reviewed by a second researcher. Please clarify whether thematic analysis, coding, etc., will solely be performed by the primary researcher. The protocol mentions an analysis team; how does their role influence the final coding process? Is the final coding completed only after the analysis team has consented to the coding framework? Additional clarity on this process would be appreciated. Discussion: In discussing the development of the intervention, it is important to consider the role of payers in the success of any future intervention. Are payer perspectives incorporated into the development of the intervention? Understanding this aspect could be crucial for addressing the needs and dynamics of the Irish healthcare system. Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Partly Are the datasets clearly presented in a useable and accessible format? Not applicable References 1. Fawsitt CG, Lucey D, Harrington P, Jordan K, et al.: A cost-effectiveness and budget impact analysis of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings in Ireland: a decision-analytic model. Fam Pract . 2022; 39 (3): 389-397 PubMed Abstract | Publisher Full Text Competing Interests No competing interests were disclosed. Reviewer Expertise GP with experience in guideline development, health services research I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (1) Author Response 07 Mar 2025 Joseph O'Shea, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin, Ireland Dear Dr Schmiemann, Thank you for taking the time to review our submission. I have addressed your comments in the revised version that has been submitted. To summarize your comments: 1. Background: Prescribing Rates in Ireland: Add a sentence referencing the ECDC report on Ireland’s antibiotic prescribing rates being slightly above the EU average. Explain how this context supports the need for interventions like POCT. Approved POCTs in Irish Primary Care: Expand the section on POCTs to clarify which ones are currently approved or used in primary care in Ireland. Economic Considerations: Acknowledge that economic factors are not the primary focus of this study but reference existing research (e.g., Fawsitt et al., 2022) in the discussion to highlight the economic feasibility of CRP POCTs in Ireland. 2. Methods: Grey Literature in Scoping Review: Add a statement that grey literature, including national projects and reports, will be reviewed alongside peer-reviewed literature. Recruitment Factors Beyond Gender: Clarify that in addition to gender, recruitment will aim for diversity in age and urban/rural practice settings. Clarification on Qualitative Analysis: Explicitly state whether thematic analysis will be conducted solely by the primary researcher or in collaboration with the analysis team. Explain the role of the analysis team in reviewing, refining, and finalizing the coding framework. 3. Discussion: Role of Payers in Intervention Development: Acknowledge that payer perspectives were not explicitly included but discuss how reimbursement models and healthcare system factors could influence future implementation. These have been addressed. The background section now includes details on antibiotic prescribing rates in Ireland and expands on existing POCTs commonly used in Irish primary care. The economic considerations section has been refined to summarize key findings from Fawsitt et al., emphasizing the cost-effectiveness and budget impact of CRP POCT implementation. In the methods section, we have clarified that grey literature will be reviewed alongside peer-reviewed sources in the scoping review. Recruitment criteria have been expanded to consider additional demographic factors, such as age and urban versus rural practice settings, to ensure a diverse participant sample. Further clarification has been added regarding qualitative data analysis, specifying the roles of the primary researcher and analysis team in coding and validation. The discussion has been revised to address the role of payers in intervention implementation, noting potential reimbursement challenges. These updates enhance the clarity and completeness of the protocol, ensuring alignment with the study's aims and the practical considerations of POCT implementation in Irish primary care. Kind regards, Dr Joseph O'Shea View more View less Competing Interests No competing interests were disclosed. reply Respond Report a concern Schmiemann G. Peer Review Report For: Protocol for the development of an intervention to improve the use of Point-of-caRE DiagnostICs in the management of respiraTOry tRact infectionS in primary care (the PREDICTORS study) [version 2; peer review: 2 approved] . HRB Open Res 2025, 7 :73 ( https://doi.org/10.21956/hrbopenres.15318.r43345) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://hrbopenresearch.org/articles/7-73/v1#referee-response-43345 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with HRB Open Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "Protocol for the development of an intervention...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://hrbopenresearch.org/articles/7-73/v2" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://hrbopenresearch.org/articles/7-73/v2&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://hrbopenresearch.org/articles/7-73/v2" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('O'Shea J et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://hrbopenresearch.org/articles/7-73/v2/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://hrbopenresearch.org/articles/7-73", templates : { twitter : "Protocol for the development of an intervention to improve the.... O'Shea J et al., published by " + "@HRBOpenRes" + ", https://hrbopenresearch.org/articles/7-73/v2" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/13962/15500") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "15500"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "43344": 0, "43345": 15, "43346": 0, "43347": 20, "43338": 0, "43339": 0, "43340": 0, "46333": 5, "43341": 0, "46334": 3, "43342": 0, "43343": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "0a9c069d-8b09-4c6f-877e-2e81fb7d66c7"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); Are you a HRB-funded researcher? Submission to HRB Open Research is open to all HRB grantholders or people working on a HRB-funded/co-funded grant on or since 1 January 2017. Sign up for information about developments, publishing and publications from HRB Open Research. First Name * You must provide your first name Last Name * You must provide your last name Email * You must provide a valid email address Institution You must provide an institution. Submit Thank you! We'll keep you updated on any major new updates to HRB Open Research HRB Open Research Browse How to Publish About Contact RSS Cookie Notice Privacy Notice Legal Submit Your Research © F1000 Research Limited and its licensors ISSN 2515-4826 | Legal background var F1000platform = new F1000.Platform({ name: "hrb", displayName: "HRB Open Research", hostName: "hrbopenresearch.org", id: "5", editorialEmail: "
[email protected]", infoEmail: "
[email protected]" }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); }); (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9fe760a46f6841e2',t:'MTc3OTIzODU0NA=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.